COMPARING THE EFFICACY OF PCOSBLESS AND OVABLESS-MYO IN THE MANAGEMENT OF GRANTHIBHUTA ARTAVADUSHTI (POLYCYSTIC OVERIAN SYNDROMES).

A COMPARATIVE CLINICAL STUDY OF PCOSBLESS AND OVABLESS-MYO IN THE MANAGEMENT OF GRANTHIBHUTA ARTAVADUSHTI WITH SPECIAL REFRENCE TO POLYCYSTIC OVERIAN SYNDROMES.

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/09/015575

Enrollment

Registered

2018-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N832- Other and unspecified ovarian cysts Health Condition 2: null- PCOS women

Interventions

Intervention1: Indigenous extract tablet formulation: 1.latakarnj beej 2.patha mool 3.Guduchi kaand 4.Shatavari kand 5.Shatpushpa phal 6.Shunthi Kand 7.marich Phal 8.Pippali phal 9. kutaj bark 10. Kri

Eligibility

Inclusion criteria

Inclusion criteria: Oligomenorrhea and/or anovulation Hyperandrogonism(clinical and/or biochemical) PCO- diagnosed by ultrasonography(USG) LH:FSH ratio > 3:1

Exclusion criteria

Exclusion criteria: Tuberculosis Carcinoma Congenital deformities Adrenal hyperplasia Severe insulin resistance thyroid abnormalities Cardiac diseases.

Design outcomes

Primary

Measure	Time frame
Beneficial in oligomenorrhea and anovulationTimepoint: three months	—

Secondary

Measure	Time frame
Beneficial in improving Polycystic ovarian syndromeTimepoint: Three months	—

Countries

India

Contacts

Public Contactdr Mansi Modi

parul institute of ayurved

mansi.modi1@gmail.com9979883317

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026